Eagleheirs Global Pharma Limited

Improving Access to Quality Medicines in South Sudan

Eagleheirs Global Pharma Limited Corporate Logo
Home Therapeutic Areas
Essential Formulary Focus

Targeted Therapeutic Categories for South Sudan

An informational overview of the essential pharmaceutical categories prioritized by Eagleheirs Global Pharma Limited to meet public health challenges in the Republic of South Sudan.

Pharmaceutical Manufacturing Facility
GMP Production Standards Alignment WHO-Prequalified Focus
Important Informational Notice & Regulatory Boundary: The therapeutic classes and molecules presented below are published strictly for corporate informational purposes, stakeholder alignment, and supply chain planning. Eagleheirs Global Pharma Limited is not an online pharmacy, does not sell medicines directly to individual consumers or patients, and does not provide clinical or prescribing advice. Every prospective pharmaceutical product is subject to regulatory clearance and registration with the Drug and Food Control Authority (DFCA) of the Republic of South Sudan prior to commercial distribution.
Antimalarial Therapies
Priority 01 · Endemic Disease

Antimalarial Therapies

Malaria remains the single leading contributor to hospital admissions and child mortality in South Sudan. Eagleheirs Global Pharma Limited prioritizes audited WHO-prequalified Artemisinin-based Combination Therapies (ACTs).

Storage Protocol: Zone IVb Controlled Ambient (≤30°C)
Target Facilities: Hospitals, PHCs, Community Dispensaries

Informational Category Description

South Sudan's hyper-endemic malaria transmission requires reliable year-round availability of both oral therapies for uncomplicated falciparum malaria and parenterals for severe pediatric and maternal malaria complications. Our planned procurement prioritizes multi-dose packaging suited for tropical humidity.

Uncomplicated Malaria Focus
• Artemether + Lumefantrine (Tablets & Dispersible)
• Artesunate + Amodiaquine
Severe & Emergency Protocols
• Injectable Artesunate (60mg, 120mg Vials)
• Artemether IM Injections
Subject to DFCA Dossier Approvals
Antibiotics & Anti-Infectives
Priority 02 · Stewardship Aligned

Antibiotics & Anti-Infectives

Essential antibacterial agents engineered to combat bacterial pneumonia, sepsis, diarrheal infections, and surgical site contamination while upholding antimicrobial stewardship.

WHO AWaRe Classification: Access & Watch Categories
Target Facilities: Hospitals, Surgical Centers, PHCs

Informational Category Description

Bacterial infections represent a frequent complication in vulnerable communities. Our proposed antibacterial portfolio is structured according to the WHO AWaRe framework to support proper clinical prescription practices and minimize the progression of antimicrobial resistance (AMR).

Access Category (First-Line)
• Amoxicillin + Clavulanic Acid (Oral & IV)
• Ampicillin & Cloxacillin formulations
• Doxycycline & Erythromycin
Watch Category (Hospital Inpatient)
• Ceftriaxone & Cefotaxime Injectable Vials
• Ciprofloxacin & Azithromycin
Subject to DFCA Dossier Approvals
Analgesics and Antipyretics
Priority 03 · Pain & Fever Management

Analgesics & Antipyretics

Vital pain relief and fever management medications essential across all outpatient consultations, postoperative recovery, trauma emergency care, and maternal health units.

Formulations: Oral Solid, Oral Liquid & IV Infusions
Target Facilities: Universal Care Coverage

Informational Category Description

Pain and high fever represent the most common presenting symptoms in South Sudanese healthcare clinics. Our proposed portfolio spans mild antipyretics suitable for pediatrics to moderate and severe analgesic therapies for surgical and trauma management.

Non-Opioid Antipyretics
• Paracetamol 500mg Tablets & 120mg/5ml Syrups
• Paracetamol 10mg/ml IV Infusions (Hospital use)
NSAIDs & Surgical Analgesia
• Ibuprofen 200mg / 400mg & Suspensions
• Diclofenac Sodium 50mg / 75mg Injectable
• Regulated hospital analgesics
Subject to DFCA Dossier Approvals
Understanding Non-Communicable Diseases
Priority 04 · Chronic Disease Care

Non-Communicable Diseases (NCDs)

Addressing South Sudan's escalating chronic disease burden with reliable maintenance therapies for hypertension, diabetes, and cardiovascular conditions.

Therapeutic Focus: Hypertension & Type 2 Diabetes
Key Challenge: Ensuring Uninterrupted Supply Cycles

Informational Category Description

While communicable illnesses dominate public health discussions, urban and semi-urban populations in South Sudan are experiencing significant rises in cardiovascular disease and diabetes. Treatment interruption in chronic conditions leads to severe strokes and renal failure; our focus is guaranteeing steady supply.

Cardiovascular & Hypertension
• Amlodipine 5mg & 10mg Tablets
• Enalapril 5mg & 10mg / Losartan 50mg
• Hydrochlorothiazide 25mg / Atenolol
Endocrine & Diabetes Care
• Metformin Hydrochloride 500mg & 850mg
• Glibenclamide & Glimepiride
• Baseline glucose monitoring consumables
Subject to DFCA Dossier Approvals
Other Healthcare Products & Consumables
Priority 05 · Hospital Essentials

Other Healthcare Products

Critical hospital consumables, intravenous replacement solutions, oral rehydration regimens, and maternal-child nutritional micronutrients.

Category Scope: Parenteral Fluids & Micronutrients
Logistics Requirement: High Bulk Volume Handling

Informational Category Description

Modern clinical care cannot function without steady access to sterile intravenous infusion fluids and oral rehydration therapies during cholera or gastrointestinal emergencies. Our planned portfolio bridges bulk hospital procurement with reliable logistics.

IV Solutions & Resuscitation
• Normal Saline (0.9% Sodium Chloride) 500ml
• Ringer’s Lactate Solution 500ml
• 5% & 10% Dextrose Infusion Bottles
Maternal & Child Health
• Low-Osmolarity Oral Rehydration Salts (ORS) + Zinc
• Iron + Folic Acid prenatal tablets
• Pediatric Vitamin A & Multivitamin drops
Subject to DFCA Dossier Approvals
Official Export Portfolio • COPP Dossiers

Master Export Formulary & Product Register

Comprehensive register of certified export formulations held under Certificate of Pharmaceutical Products (COPP) standards by Eagleheirs Global Pharma Limited. All formulations comply with internationally recognized monographs (USP, BP, IP) and WHO-GMP manufacturing controls.

# Product Composition & Strength Therapeutic Class Pharmacopeia Dosage Form COPP Status
01 Sildenafil Citrate Tablets 100mg Men's Health / Vasodilator USP Tablets Ready COPP
02 Gastro-Resistant Omeprazole Capsules 20mg Gastroenterology / Proton Pump Inhibitor BP Capsules (Enteric Pellets) Ready COPP
03 Mupirocin Ointment 2% w/w Dermatology / Topical Antibacterial USP Topical Ointment Ready COPP
04 Ofloxacin Tablets 200mg Anti-Infective / Fluoroquinolone USP Film-Coated Tablets Ready COPP
05 Fusidic Acid Cream 2.0% w/w Dermatology / Primary Skin Infections BP Topical Cream Ready COPP
06 Acetaminophen (Paracetamol) Tablets 500mg Analgesic & Antipyretic First-Line USP Tablets Ready COPP
07 Azithromycin Tablets 250mg Macrolide Antibiotic / Respiratory USP Film-Coated Tablets Ready COPP
08 Azithromycin Tablets 500mg Macrolide Antibiotic / Respiratory & Enteric USP Film-Coated Tablets Ready COPP
09 Clobetasol Propionate 0.05% + Chlorocresol 0.1% Cream Dermatology / Corticosteroid Anti-inflammatory USP Topical Cream Ready COPP
10 Calcium Carbonate Tablets 1250mg Nutritional Supplement / Mineral Health USP Tablets Ready COPP
11 Rabeprazole Gastro-Resistant Tablets 20mg Gastroenterology / Acid Reflux & Ulcers USP Enteric Tablets Ready COPP
12 Ketoconazole Cream 2.0% w/w Dermatology / Broad-Spectrum Antifungal BP Topical Cream Ready COPP
13 Povidone-Iodine Ointment 5.0% w/w Antiseptic / Wound Care & Burns USP Topical Ointment Ready COPP
14 Diclofenac Potassium 50mg + Acetaminophen 325mg Tablets Analgesic / Moderate-to-Severe Pain USP Tablets Ready COPP
15 Aceclofenac 100mg + Acetaminophen 325mg Tablets NSAID / Joint & Musculoskeletal Pain BP / USP Tablets Ready COPP
16 Diclofenac Sodium 50mg + Serratiopeptidase 10mg Tablets Anti-inflammatory & Anti-Edema Enzyme Combo USP Enteric Tablets Ready COPP
17 Diclofenac Diethylamine + Linseed Oil + Menthol + Methyl Salicylate Gel Topical Pain Relief Gel (1.16% / 3.0% / 5.0% / 10.0%) BP / USP Topical Gel Ready COPP
18 Diclofenac + Linseed Oil + Menthol + Methyl Salicylate + Capsaicin Gel Advanced Arthritic & Deep Muscular Pain Gel BP / USP Topical Gel Ready COPP
19 Luliconazole Cream 1.0% w/w Broad-Spectrum Tropical Antifungal (Tinea/Ringworm) IH / USP Topical Cream Ready COPP
20 Ketorolac Tromethamine Tablets 10mg Post-Operative & Acute Severe Pain USP Film-Coated Tablets Ready COPP
21 Pregabalin 75mg + Methylcobalamin 750mcg Capsules Neuropathic Pain & Diabetic Peripheral Nerve Health USP Hard Gelatin Capsules Ready COPP
22 Artemether & Lumefantrine Tablets 20/120mg Antimalarial ACT First-Line (Pediatric / Baseline) USP Dispersible / Tablets Ready COPP
23 Artemether & Lumefantrine Tablets 40/240mg Antimalarial ACT First-Line (Intermediate Dose) USP Tablets Ready COPP
24 Artemether & Lumefantrine Tablets 80/480mg Antimalarial ACT First-Line (Adult High Dose) USP Tablets Ready COPP
25 Amoxycillin & Potassium Clavulanate Tablets 625mg Beta-Lactam Antibiotic (Amox 500mg + Clav 125mg) IP / BP Coated Tablets (Alu-Alu) Ready COPP
26 Amoxycillin Capsules 500mg Broad-Spectrum Penicillin Antibiotic IP / BP Capsules Ready COPP
27 Amoxycillin & Potassium Clavulanate Oral Suspension 3.3gm/30ml Pediatric Anti-Infective Suspension IP / BP Dry Powder for Oral Susp. Ready COPP
28 Atorvastatin Calcium Tablets 20mg Cardiovascular / Lipid Lowering Statin USP Film-Coated Tablets Upcoming Pipeline
29 Pregabalin 75mg + Methylcobalamin 1500mcg + Nortriptyline 10mg Tablets Advanced Neuropathic Pain & Fibromyalgia BP / USP Tablets Upcoming Pipeline
30 Gabapentin 300mg + Methylcobalamin 500mcg Tablets Neuropathic Pain & Neuro-Nutritional Care BP / USP Tablets Upcoming Pipeline
31 Aceclofenac 100mg + Paracetamol 325mg + Chlorzoxazone 250mg Tablets Muscle Relaxant & Severe Spasm Pain Relief BP / USP Tablets Upcoming Pipeline
32 Diclofenac Potassium 50mg + Paracetamol 325mg Tablets Rapid-Onset Analgesic & Anti-inflammatory BP Tablets Upcoming Pipeline
33 Aceclofenac 100mg + Paracetamol 325mg + Cetirizine 10mg + Phenylephrine 5mg + Caffeine 25mg Multi-Action Cold, Sinusitis & Pyrexia Relief BP Tablets Upcoming Pipeline
34 Nimesulide 100mg + Paracetamol 325mg Tablets Acute Inflammatory Pain & Fever Management BP Tablets Upcoming Pipeline
35 Lornoxicam 4mg + Paracetamol 325mg Tablets Potent Oxicam NSAID for Joint & Post-Surgical Pain IH / BP Tablets Upcoming Pipeline
36 Omeprazole Capsules 40mg (Enteric Coated Pellets) High-Dose Proton Pump Inhibitor (Severe GERD) BP Enteric Pellets in Capsules Upcoming Pipeline
37 Esomeprazole 40mg + Domperidone 30mg (SR) Capsules Acid Reflux & Gastro-Motility Dual Action BP Sustained Release Capsules Upcoming Pipeline
38 Duloxetine Gastro-Resistant Tablets 30mg Neuropathic Pain & Depressive Disorders (SNRI) BP Enteric Coated Tablets Upcoming Pipeline
39 Esomeprazole Gastro-Resistant Tablets 40mg Next-Gen PPI / Peptic Ulcer Healing BP Enteric Tablets Upcoming Pipeline
40 Flupentixol HCL 0.5mg + Melitracen 10mg Tablets Psychosomatic & Anxiety-Depressive States USP Sugar-Coated Tablets Upcoming Pipeline
41 Aceclofenac 100mg + Thiocolchicoside 4mg Tablets Anti-inflammatory Muscle Relaxant Combo BP Tablets Upcoming Pipeline
42 Ondansetron Orally Disintegrating Tablets 4mg Anti-Emetic (Nausea & Vomiting Relief) USP Fast-Dissolve ODT Upcoming Pipeline
43 Ondansetron Orally Disintegrating Tablets 8mg Anti-Emetic (High-Dose Hospital Post-Chemo/Surgical) USP Fast-Dissolve ODT Upcoming Pipeline
44 Rosuvastatin Calcium 10mg + Fenofibrate 145mg Tablets Mixed Dyslipidemia & Hypertriglyceridemia BP Tablets Upcoming Pipeline
45 Folic Acid Tablets 5mg Maternal Health, Prenatal Care & Anemia Prevention USP Tablets Upcoming Pipeline
46 Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg Tablets Beta-Lactam / Resistant Respiratory & Soft Tissue Infections BP Film-Coated Tablets Upcoming Pipeline
47 Amoxycillin Trihydrate Capsules 500mg First-Line Extended Spectrum Penicillin BP Capsules Upcoming Pipeline
48 Pantoprazole 40mg + Domperidone 10mg Tablets Acid Reflux & Gastric Ulcer Symptom Management BP Enteric Tablets Upcoming Pipeline
49 Dapagliflozin Tablets 10mg Type-2 Diabetes SGLT2 Inhibitor & Renal/Cardio Protection USP Film-Coated Tablets Upcoming Pipeline
50 Torsemide 10mg + Spironolactone 25mg Tablets Hypertension, Congestive Heart Failure & Edema Diuretic USP / BP Tablets Upcoming Pipeline
COPP Verification & Statutory Dossiers: Commercial availability is governed by Drug and Food Control Authority (DFCA) product registrations. Certificates of Pharmaceutical Products (COPP) issued in accordance with WHO Certification Scheme.